Awaiting product image

Article: Efficacy and safety of ponatinib in CP-CML patients by number of prior TKIs: 4-year follow-up of the phase 2 PACE trial

€2.42

SKU: product-article-17960 Category:

Description

Efficacy and safety of ponatinib in CP-CML patients by number of prior TKIs: 4-year follow-up of the phase 2 PACE trial

Reviews

There are no reviews yet.

Be the first to review “Article: Efficacy and safety of ponatinib in CP-CML patients by number of prior TKIs: 4-year follow-up of the phase 2 PACE trial”

Your email address will not be published. Required fields are marked *

Related products